Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYBU antisense RNA 1 (SYBU-AS1)
- Target
- SYBU-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
SYBU antisense RNA 1 (SYBU-AS1), also known as AC079061.1, is a long non-coding RNA transcribed from the SYBU gene locus. It does not code for a protein. Recent research suggests that lncRNA-AC079061.1 may regulate the immune microenvironment and suppress the proliferation and invasion of hepatocellular carcinoma cells by affecting the expression of VIPR1, an immune-related gene. Its high expression is associated with improved prognosis for patients with HCC[2]. Beyond this cancer-associated context, there is no evidence linking SYBU-AS1 directly to recognized therapeutic interventions, receptor-mediated mechanisms, or traditional drug targeting.
- Other names
- AC079061.1
02
Biological functions
Potential regulation of gene expressionPossible modulation of the tumor immune microenvironment via the VIPR1 axis in hepatocellular carcinoma (HCC)
03
Disease associations
Cancer (specifically, may function as a biomarker in hepatocellular carcinoma; high expression is associated with favorable prognosis in HCC)
04
Biomarkers
Potential biomarker for prognosis in hepatocellular carcinoma (patients with higher expression have better outcomes)
Beyond the preview
Go deeper on SYBU antisense RNA 1 (SYBU-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYBU antisense RNA 1 (SYBU-AS1).